Delivering state-of-the-art care for GEP-NETs: Evidence-based strategies for PRRT
Description
touchPANEL DISCUSSION for touchONCOLOGY and touchENDOCRINOLOGY
Listen to a panel of leading experts discuss the optimal management of gastroenteropancreatic neuroendocrine tumours (GEP-NETs), with a focus on peptide receptor radionuclide therapy (PRRT). The faculty provide their insights on the current state of the art, the evolving role of PRRT in GEP-NET treatment, and recent data with existing and emerging PRRT agents. The faculty will also consider future developments in this field, including personalized approaches to PRRT, and how they might impact clinical care.
The experts:
- Prof. Thorvardur Halfdanarson, Mayo Clinic Rochester, MN, USA
- Prof. Rocio Garcia-Carbonero, Hospital Universitario 12 de Octubre, Madrid, Spain
- Prof. Nicola Fazio, European Institute of Oncology, Milan, Italy
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from ITM Isotope Technologies Munich SE.
The activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our websites: www.touchONCOLOGY.com and www.touchENDOCRINOLOGY.com
United States
